Followers | 62 |
Posts | 4507 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Saturday, September 27, 2014 10:43:14 AM
At the end of the day the traders have been right all along. But, that doesn't mean that someday the believers won't be rewarded yet "again" with nice pops and higher market caps. The variable in the equation is how many shares will be outstanding when it does, diluting those millionaire dreams.
2010 teenish to 1.70ish
2012 .12ish to .60ish
2013/2014 .05ish to .40ish
Those are multi bagger trades folks. Even if you only got a piece of it, not necessarily the extreme tops and bottoms. If you look up the number of outstanding shares during those periods you might understand it from the trader perspective. It's all about the math until there is a big break through in commercialization or if a whale buys the tech.
For now the traders win. Maybe this Hauck is really the "guy". Hopefully LQMT at some point soon will stop the bleeding of the mega dilution trend.
LQMT can still be a viable long term lotto opportunity. At the right entry proce. If the slackers would only stop lining their pockets with the dilution until they actually commercialize the product it would go a long way in rebuilding faith in the intentions of management. At least for me.
Just my opinion.
Let's keep it civil and understand that this is a forum of mostly amateur opinions. I am not here to give advice or argue. The best way to get rid of trolls is by using the ignore feature. And if you don't like what I say feel free to ignore me. Thanx.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM